Dr Hari Nair

Dr Hari Nair

Executive Chairman

Dr Nair has a PhD in Medicine and Clinical Science from the Australian National University with his specialty in cardiovascular medicine and haematology. Dr Nair has received a number of awards from international organisations including being specially recognised for his role in coagulation research by the Australian Capital Territory government. He has run biotechnology companies in Australia and the US. Dr Nair has been heavily involved in mergers and acquisitions especially in the US and Europe and has US financial experience. Dr Nair’s corporate experience include Financial raisings, corporate public relations and organisational integration strategies, Human Resources, IP strategy and management, financial management and Research and Development. Dr Nair is an expert in Coagulation Science with a special emphasis on fibrinogen. Dr Nair is the author of over 100 research publications and has had over 50 patents on various aspects of the PrIME technology and its application in both plasma protein separations, renal dialysis and cellular separations. He discovered the use of nano carbon particles in the use of radiographic imaging of blood clots. Dr Nair is a co-inventor of the PrIME technology and has developed various applications of this technology especially relevant to plasma protein fractionation. Dr Nair together with Mr John Manusu also ran the then world’s largest independent plasma collection organization based in the United States. This business collected both normal and specialty plasmas, including hyperimmunes for the US Government bioterrorism program. Dr Nair has served on the boards of a number of international biotechnology companies and US state Commercialisation Boards for Georgia, Florida and Alabama.


Go Back